Welcome to our May 2021 Newsletter!
Watch for a new mini edition each month...
View this email in your browser

In This Issue

  • COVID-19 Policy Updates
  • New NSIV Member
  • Keeping up with NSIV 
  • Keeping up with NSIV Graduates
  • What's going on

NSIV Website

Find all these stories and more on our website! Stay informed at

Keep Up With Us

LinkedIn LinkedIn
Twitter Twitter
Facebook Facebook
YouTube YouTube
COVID-19 Policy Updates

NSIV no longer requires those employees who are fully vaccinated, two weeks after receiving 1 dose and or two doses depending on the type of vaccine, to wear a mask.  The same policy applies to guests.

The EEOC offered long-awaited guidance on the permissibility of employer programs that offer incentives to employees who receive COVID-19 vaccinations.  Read more here.

Massachusetts Governor Charlie Baker signed into law legislation requiring all Massachusetts employers to provide emergency paid sick leave to employees who are unable to work for certain reasons relating to COVID-19 (“EPSL”).  Learn more about the specifics here.  

New NSIV Member

TellBio is a development-stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and propriety circulating tumor cells (CTCs) technology, TellDx and complementary therapeutic platform, TellRx.  Similar to its namesake William Tell, (an expert marksman who delivered his people from a tyrant leader), TellBio's vision is to free patients and their families from the tranny of cancer via both its TellDx, and TellRx platforms.

TellBio recently closed Series A financing of $5 million and hired an executive leadership team including Pritesh Gandhi as CEO and Annie Patisano as SVP and Head of Operations.
Keeping Up with NSIV
Genomic has added to the dashboard of its online web-based platform a vaccination status which allows companies to deselect employees from their testing program once they have been vaccinated.

Also, Gitte Pedersen, the CEO of Genomic, was chosen to present at the OneRNA® at the Frontiers in Cancer immunotherapy Meeting which was hosted virtually last month by the New York Academy of Sciences.  She presented Genomic's unpublished OneRNA
® findings in breast for the first time.

Keeping up with NSIV Graduates
Thrive Bioscience was recently chosen to compete at Invest Pitch Perfect.  The Pitch Perfect contest includes five tracks for startups: biopharma, medical devices, diagnostics, health IT and health services.  The event unites active investors with corporate business development executives to facilitate investment opportunities with the most promising startups.

What's Going On?

JUNE 24th from 5:00 PM - 5:45 PM
Virtual Networking Event: Beverages, Biosciences and Board
Virtual Networking Event - Biosciences


Whether you’re a startup seeking capital and exposure, or an investor seeking new deals, Venture Summit \ Virtual Connect [Global] presented by youngStartup Ventures - is the event of the year you won't want to miss.
A highly productive venture conference, this exclusive program is dedicated to showcasing early-stage VCs, Corporate VCs, and angel investors committed to funding venture-backed, emerging, and early-stage companies as well as showcasing over 100 Top Innovators.

ACTION Innovation Network has made a special arrangement for our network to receive a steep discount of 20% off the existing “early bird" savings. This conference will be attended by the best people in the industry. Please register early to avoid disappointment.  Register Today & Save Click here (Use promo code "ACTIONVIP”)

Copyright © 2021 North Shore InnoVentures, All rights reserved. 
You are receiving our newsletter because you have indicated that you wished to receive updates on NSIV events and news. Please let us know how we can best keep you up to date! 
Our mailing address is: 
North Shore InnoVentures
100 Cummings Center
Suite 451C
Beverly, MA 01915
Add us to your address book
Email Marketing Powered by MailChimp
 unsubscribe from this list | update subscription preferences 

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
North Shore InnoVentures · 100 Cummings Center · Suite 451C · Beverly, MA 01915 · USA

Email Marketing Powered by Mailchimp